Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects

Clinical trial NCT02363855 · COMPLETED

Trial details

NCT number: NCT02363855
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2015-02-23
Primary completion: 2015-11-19
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.